Mounjaro's generic name is tirzepatide, a dual GIP and GLP-1 receptor agonist. Learn how it compares to semaglutide, dosing, price, and safety.
The generic name for Mounjaro is tirzepatide. Mounjaro is the brand name Eli Lilly uses for tirzepatide when the drug is prescribed to treat type 2 diabetes, while Zepbound is the same active ingredient marketed for weight management. In other words, tirzepatide is the drug itself, and Mounjaro is one of the labels it is sold under in the United States.
What Is the Generic Name of Mounjaro?
Tirzepatide is the nonproprietary, or generic, name of the active ingredient in Mounjaro. Every prescription drug has one generic name that identifies the molecule, regardless of which company sells it or what brand name appears on the box.
Mounjaro is a once-weekly injectable that the FDA approved in May 2022 as an adjunct to diet and exercise for adults with type 2 diabetes. The same molecule was later approved under the brand name Zepbound for chronic weight management and, in 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity.
| Brand Name | Generic Name | Manufacturer | Primary Approved Use |
|---|---|---|---|
| Mounjaro | Tirzepatide | Eli Lilly | Type 2 diabetes |
| Zepbound | Tirzepatide | Eli Lilly | Chronic weight management; obstructive sleep apnea |
Because both brands share the same generic name, tirzepatide, the difference between Mounjaro and Zepbound comes down to FDA-approved indication, labeling, and insurance coverage — not the molecule itself. Knowing the generic name also matters in practical settings, because insurance formularies, prior authorization forms, and pharmacy records are organized around tirzepatide rather than around a single brand.
How Tirzepatide Works in the Body
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It mimics two naturally occurring incretin hormones that help regulate blood sugar, slow stomach emptying, and influence appetite signaling in the brain.
Semaglutide, by contrast, targets only the GLP-1 receptor. The receptor difference is why people comparing the ingredients in ozempic vs mounjaro often find that the two drugs produce different results in clinical trials.
Is Mounjaro the Same as Semaglutide?
No. Mounjaro contains tirzepatide, and semaglutide is a completely different molecule with its own generic name. Many searchers ask is mounjaro the same as semaglutide, and the accurate answer is that they belong to a related drug class but are not interchangeable.
| Feature | Tirzepatide (Mounjaro, Zepbound) | Semaglutide (Ozempic, Wegovy, Rybelsus) |
|---|---|---|
| Receptor targets | GIP and GLP-1 | GLP-1 only |
| Manufacturer | Eli Lilly | Novo Nordisk |
| Available forms | Once-weekly injection | Weekly injection; daily oral tablet |
| Approved uses | Type 2 diabetes; weight management; sleep apnea | Type 2 diabetes; weight management; cardiovascular risk reduction |
Both drugs are prescription-only, and both can cause gastrointestinal side effects. Neither is a cosmetic product, and neither should be started without a clinician's evaluation.
Is There a Generic Tirzepatide Yet?
As of 2025, there is no FDA-approved generic version of tirzepatide sold in the United States. Brand-name Mounjaro and Zepbound remain under patent protection, so pharmacies cannot dispense a true generic equivalent.
When people search for tirzepatide generic price, they often land on compounded products instead. During a supply shortage, some compounding pharmacies prepared their own tirzepatide. The FDA has since declared the shortage resolved, and compounded tirzepatide is now restricted and the subject of ongoing litigation.
Compounded drugs are not FDA-approved, which means their strength, purity, and stability are not reviewed the same way as brand-name Mounjaro. Manufacturer copay cards, insurance formulary coverage, and direct-to-consumer pharmacy programs are the more reliable ways to lower out-of-pocket costs.
Dosing, Cost, and Safety Basics
Mounjaro is injected subcutaneously once a week, on the same day each week, with or without food. The labeled starting dose is 2.5 mg once weekly for four weeks, after which the dose is usually increased to 5 mg and titrated as needed up to a maximum of 15 mg per week.
Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite. More serious risks listed on the label include pancreatitis, gallbladder disease, kidney injury from dehydration, and hypoglycemia when tirzepatide is combined with insulin or sulfonylureas.
Mounjaro carries a boxed warning about thyroid C-cell tumors observed in rodents, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2. Anyone wondering whether tirzepatide is appropriate for them should speak with a licensed healthcare professional.
Mounjaro is supplied as a prefilled single-dose pen or a single-dose vial, and doses should never be split, mixed, or compounded at home. Altering a prescription injectable can lead to dosing errors and serious adverse effects.
Newer Options and Ongoing Research
Researchers are studying next-generation incretins, and searches for retatrutide brand name reflect interest in a triple agonist that is still investigational. Retatrutide has not been approved by the FDA, and no commercial brand name has been finalized.
Some people ask how to switch from mounjaro to retatrutide, but no approved clinical pathway exists for that switch today. Enrollment in a clinical trial is currently the only legal way to receive retatrutide in the United States.
For now, tirzepatide remains the generic name behind Mounjaro, and it is the same molecule sold under the brand name Zepbound. Comparing brand names, approved uses, and total cost is the most practical way to understand what a prescription actually contains.
Frequently Asked Questions
What is the generic name for Mounjaro?
The generic name for Mounjaro is tirzepatide. Mounjaro is Eli Lilly's brand name for tirzepatide when it is prescribed for type 2 diabetes, and Zepbound is the same molecule approved for chronic weight management and obstructive sleep apnea.
Is there a generic version of Mounjaro in the United States?
No. There is no FDA-approved generic tirzepatide sold in the U.S. as of 2025. Brand-name Mounjaro and Zepbound remain under patent, and compounded tirzepatide products are not FDA-approved.
Is Mounjaro the same as Ozempic or semaglutide?
No. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, while Ozempic and Wegovy contain semaglutide, which targets only GLP-1. They are different drugs and are not interchangeable without a healthcare professional's guidance.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.